They also found a fraction of MM cell lines and primary tumors aberrantly expressed IL-22RA1 and demonstrated that IL-22 induced STAT-3 phosphorylation, cell growth, and resistance to drug. The gene discussed is IL22RA1; the disease is Miyoshi myopathy.